SBC Medical Group Holdings Incorporated SBC
4.90
0.15
3.16%
as of 25 Sep
- Market cap
- $488.5M
- P/E
- 10.4×
Follow SBC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
19.10% | 22.25% | 16.42% | 18.69% | |
| 14.02% | 15.77% | 12.13% | 13.58% | ||
ROIC |
26.15% | 29.67% | 26.61% | 30.71% | |
Return on Tangible Assets |
22.85% | 28.70% | 22.23% | 26.03% | |
Average Days of Receivables |
150.59 | 83.64 | 96.13 | 105.90 | |
Free Cash Flow per Share |
(0.33) | 0.29 | 0.36 | 0.65 | |
Free Cash Flow |
(33.88) | 29.78 | 36.96 | 66.45 | |
Capital Expenditures |
0.72 | 5.11 | 4.99 | 3.63 | |
Piotroski F-Score |
3.00 | 3.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(8.72%) | 5.24% | 6.68% | 12.51% | |
Accounts Receivable Turnover |
2.99 | 4.32 | 3.95 | 3.06 | |
Accounts Payable Turnover |
2.64 | 2.88 | 2.56 | 2.28 | |
Inventory Turnover |
25.24 | 21.61 | 24.61 | 21.05 | |
Average Days of Payables |
158.69 | 138.99 | 145.40 | 175.93 | |
Days of Inventory on Hand |
13.24 | 22.00 | 17.16 | 22.06 | |
Tax Rate |
(0.38) | (0.38) | (0.41) | (0.34) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
32.40% | 34.44% | 34.78% | 34.51% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.80) | 0.48 | 0.78 | 1.28 | |
Depreciation/Fixed assets |
0.42 | 0.36 | 0.37 | 0.43 | |
Capex/Depreciation |
0.25 | 1.90 | 1.83 | 1.13 | |
Revenue per Share |
1.74 | 1.69 | 1.65 | 1.71 | |
Operating CF per Share |
(0.34) | 0.24 | 0.31 | 0.61 | |
Capex per Share |
0.01 | 0.05 | 0.05 | 0.04 | |
Capex to Sales |
0.00 | (0.03) | (0.03) | (0.02) | |
Net Profit Margin |
24.28% | 29.37% | 24.09% | 27.99% |
Columns are period end dates